Male Infertility Market in Asia Pacific would register a CAGR of 8.9% during 2020-2026

Published Date: 16-Jul-2020

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report Asia Pacific Male Infertility Market, published by KBV research, the Asia Pacific Male Infertility Market would witness market growth of 8.9% CAGR during the forecast period (2020-2026).

The India market dominated the Asia Pacific Sperm Agglutination Market by Country in 2019, growing at a CAGR of 5.1 % during the forecast period. The China market is estimated to grow at a CAGR of 11.8% during (2020 - 2026). Additionally, The Japan market is witnessing a CAGR of 10.2% during (2020 - 2026).

The Assisted Reproductive Technology and Varicocele Surgery market dominated the South Korea Male Infertility Market by Treatment in 2019, thereby, achieving a market value of $58.2 million by 2026, growing at a CAGR of 9.2 % during the forecast period. Additionally, The Medication market is expected to witness highest CAGR of 10% during (2020 - 2026).

The DNA Fragmentation Technique market dominated the Malaysia Male Infertility Market by Test in 2019, growing at a CAGR of 8.7 % during the forecast period. The Oxidative Stress Analysis market would exhibit a CAGR of 10.4% during (2020 - 2026). Additionally, The Computer Assisted Semen Analysis market is anticipated to grow at a CAGR of 10.4% during (2020 - 2026).

Structural Insights: https://www.kbvresearch.com/asia-pacific-male-infertility-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Sanofi S.A., Bayer AG, Cadila Healthcare Ltd. (Zydus Cadila), Endo International PLC, Aytu BioScience, Inc., Vitrolife AB, SCSA Diagnostics, Inc., Andrology Solutions Limited, Halotech DNA SL, and Intas Pharmaceutical Ltd.

Asia Pacific Male Infertility Market Segmentation

By Treatment

  • Assisted Reproductive Technology & Varicocele Surgery
  • Medication

By Tests

  • DNA Fragmentation Technique
  • Oxidative Stress Analysis
  • Computer Assisted Semen Analysis
  • Microscopic Examination
  • Sperm Agglutination
  • Sperm Penetration Assay
  • Other Tests

By Country

  • China Male Infertility Market
  • Japan Male Infertility Market
  • India Male Infertility Market
  • South Korea Male Infertility Market
  • Singapore Male Infertility Market
  • Malaysia Male Infertility Market
  • Rest of Asia Pacific Male Infertility Market

Companies Profiled

  • Sanofi S.A.
  • Bayer AG
  • Cadila Healthcare Ltd. (Zydus Cadila)
  • Endo International PLC
  • Aytu BioScience, Inc.
  • Vitrolife AB
  • SCSA Diagnostics, Inc.
  • Andrology Solutions Limited
  • Halotech DNA SL
  • Intas Pharmaceutical Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Male Infertility Market Related Reports:

Global Market

North America Market

Europe Market

LAMEA Market

Request For Sample


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.